The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation

Anandamide was the first brain metabolite shown to act as a ligand of “central” CB1 cannabinoid receptors. Here we report that the endogenous cannabinoid potently and selectively inhibits the proliferation of human breast cancer cells in vitro. Anandamide dose-dependently inhibited the proliferation...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: De Petrocellis, Luciano, Melck, Dominique, Palmisano, Antonella, Bisogno, Tiziana, Laezza, Chiara, Bifulco, Maurizio, Di Marzo, Vincenzo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The National Academy of Sciences 1998
Gaiak:
Biological Sciences
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC20983/
https://ncbi.nlm.nih.gov/pubmed/9653194
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak